Showing posts with label INC Research (INCR). Show all posts
Showing posts with label INC Research (INCR). Show all posts
Tuesday, December 23, 2014
Friday, November 21, 2014
INC Research Holding (INCR) began trading on the NASDAQ on 7 November 2014
Description
INC Research Holdings Inc (INC Research) is a contract research organization (CRO). The Company is engaged in Strategic clinical development, which provides a range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry; Standalone services, such as Project management, Data and biostatistics, Monitoring, Quality and compliance, Safety and pharmacovigilance, Regulatory affairs, Study start-up, Patient recruitment, Pregnancy registries, Abuse liability, Alcohol interactions and Medical writing, and Pharmaceutical consulting. The Company operates in North America, South America, Central Europe, Southern Europe, Western Europe, Middle East, Asia Pacific and Africa. The Company uses web-based electronic endpoint adjudication systems and monitoring techniques.
Address
3201 Beechleaf Ct Ste 600
RALEIGH, NC 27604-1500
United States
RALEIGH, NC 27604-1500
United States
Website
https://www.incresearch.comKey stats and ratios
| Q3 (Sep '14) | 2013 | |
| Net profit margin | 4.20% | -4.17% |
| Operating margin | 7.61% | 3.16% |
| EBITD margin | - | 10.23% |
| Return on average assets | 3.82% | -3.33% |
| Return on average equity | 17.12% | -14.17% |
| Employees | 5,500 |
Subscribe to:
Posts (Atom)